Improved high-performance liquid chromatographic assay for the determination of procainamide and its N-acetylated metabolite in plasma: application to a single-dose pharmacokinetic study.
E Lessard, A Fortin, A Coquet, P M Bélanger, B A Hamelin, J Turgeon
Index: J. Chromatogr. Sci. 36(1) , 49-54, (1998)
Full Text: HTML
Abstract
An improved high-performance liquid chromatographic assay for the determination of procainamide and N-acetylprocainamide (NAPA) at concentrations observed up to 32 h after a single oral dose administration of procainamide to human subjects is reported. Following liquid-liquid extraction of plasma samples, procainamide, NAPA, and the internal standard (N-propionylprocainamide) are separated on a reversed-phase C8 column with retention times of 4.0, 6.7, and 13.2 min, respectively. The ultraviolet detection limit (wavelength, 280 nm) of procainamide and NAPA is 2 ng/mL (signal-to-noise ratio, 3:1), and the quantitation limit is 4 ng/mL (signal-to-noise ratio, 5:1). Intra- and interday coefficients of variation are less than 8% in the range of 20-500 ng/mL.
Related Compounds
Related Articles:
Chemical genetics reveals a complex functional ground state of neural stem cells.
2007-05-01
[Nat. Chem. Biol. 3(5) , 268-273, (2007)]
2015-01-01
[Drug Metab. Dispos. 43(1) , 126-39, (2014)]
2007-07-01
[Arch. Pathol. Lab. Med. 131(7) , 1094-8, (2007)]
1996-06-01
[J. Pharm. Sci. 85(6) , 595-9, (1996)]
1995-04-01
[J. Pharmacol. Exp. Ther. 273(1) , 315-9, (1995)]